Results 61 to 70 of about 63,269 (245)
Graduate School Commencement Exercises Program, May 17, 2007 [PDF]
, 2007 Graduate School Commencement Exercises Program, May 17 ...
core +1 more source
Molecular Oncology, EarlyView.We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Graduate School Commencement Exercises Program, May 18, 2001 [PDF]
, 2001 Graduate School Commencement Exercises Program, May 18 ...
core +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, EarlyView.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Antisemitism and anti-Israel Displays at American Medical School Commencement Ceremonies in 2024
Introduction. Antisemitism has been increasing in U.S. medicine since the Hamas attack on Israel of October 7, 2023. This included anecdotal reports of antisemitic and anti-Israel displays at medical school commencements. We studied such behavior at the 25 top-ranked U.S.
Steven Roth, Hedy Wald
openaire +1 more source
Pennington to Mary & Cecil Pearson, June 3, 1965
, 1965 Pennington writing to Mary & Cecil about the commencement program at the college.https://digitalcommons.georgefox.edu/levi_pennington/1297/thumbnail ...
Pennington, Levi T.
core
Archway Commencement Issue, May 22, 1993. [PDF]
, 1993 1993 Archway Commencement ...
core +1 more source
Molecular Oncology, EarlyView.Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Archway Commencement Issue, May 21, 1994. [PDF]
, 1994 1994 Archway Commencement ...
core +1 more source
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source